3D PET/CT 铷-82 PET 心肌血流量化:半剂量与全剂量方案比较
本研究纳入20例患者在同一成像时段内重复静息扫描,分别采用全剂量(FD)与半剂量(HfD)铷-82 PET方案,评估PET系统饱和的频率与影响。FD方案中4/20(20%)出现饱和效应,HfD方案20例均无饱和;HfD较FD剂量降低47%,校正后两者MBF无差异。作者认为HfD方案可消除饱和风险,应替代临床FD方案以避免错误结果。
要点
- 全剂量铷-82方案在3D PET/CT中4/20(20%)出现饱和效应,半剂量方案20例均无饱和。
- 半剂量方案较全剂量剂量降低47%(全剂量1247±196 MBq vs 半剂量662±115 MBq)。
- 经偏倚校正后全剂量与半剂量MBF无差异(全剂量0.97±0.28 vs 半剂量校正后0.98±0.25 ml/g/min,p=0.77)。
核心结论
- 使用推荐的全剂量方案进行3D PET/CT铷-82 MBF研究时,饱和效应可能成为问题。
- 半剂量方案可消除饱和风险,作者认为应替代临床方案以避免错误结果。
研究设计与样本
- 本研究纳入20例患者,在同一成像时段内重复静息扫描,分别采用全剂量方案与半剂量方案。
- 基于输入函数与正弦图的视觉评估判断数据集是否饱和。
- 采用Bland-Altman图、变异系数(CV)与配对t检验比较全剂量与半剂量MBF测量值。
- 仅使用无饱和的数据集生成允许全剂量/半剂量序列分析的校正因子。
主要发现
- 半剂量方案剂量降低47%(全剂量1247±196 MBq vs 半剂量662±115 MBq)。
- 全剂量扫描中4/20(20%)观察到饱和效应,半剂量扫描20例均未观察到。
- 全剂量与半剂量MBF评估的偏倚为0.09 ml/g/min(全局MBF,全剂量1.03±0.29 vs 半剂量0.94±0.22 ml/g/min,p=0.001)。
- 排除视觉识别饱和效应的患者(N=4)后,偏倚降至0.05 ml/g/min(全局MBF,全剂量0.97±0.28 vs 半剂量0.92±0.23 ml/g/min,p=0.02)。
- 基于无饱和效应的数据集生成偏倚校正:校正后半剂量MBF=1.09×半剂量MBF-0.03 ml/g/min;校正后全剂量与半剂量MBF无差异(全剂量0.97±0.28 vs 半剂量校正后0.98±0.25 ml/g/min,p=0.77)。
关键数值与推荐
- 当前推荐铷-82弹丸式注射1100-1500 MBq,在多数在用3D PET/CT系统上存在PET系统饱和的潜在风险。
- 全剂量方案中4/20(20%)出现饱和效应,半剂量方案中0/20出现饱和效应。
- 半剂量方案剂量降低47%(全剂量1247±196 MBq vs 半剂量662±115 MBq)。
- 偏倚校正公式:校正后半剂量MBF=1.09×半剂量MBF-0.03 ml/g/min。
临床怎么用
- 作者认为,半剂量方案可消除饱和风险,应替代临床方案以避免错误结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Quantification of myocardial blood flow (MBF) has become central in the clinical application of Rubidium-82 (82Rb) PET myocardial perfusion scans. Current recommendations suggest injections of 1100-1500 MBq of 82Rb in bolus form, which poses a potential risk of PET system saturation on most 3D PET/CT systems currently being used. We aimed to evaluate the frequency and impact of PET system saturation and to test the potential use of a half-dose acquisition protocol. METHODS: This study comprised 20 patients who underwent repeated rest scans in a single imaging session, one employing a full-dose (FD), and the other scan a half-dose (HfD) protocol. Datasets were evaluated for saturation based on visual assessments of input functions and sinograms. We compared FD and HfD MBF measurements using Bland-Altman plots, coefficients of variation (CV), and paired t tests. A correction factor permitting serial analyses using FD/HfD imaging protocols was obtained using only the datasets without saturation. RESULTS: A dose reduction of 47% was reported for the HfD protocol (FD, 1247 ± 196 MBq; HfD, 662 ± 115 MBq). Saturation effects were observed in 4/20 (20%) FD scans, with none observed in the 20 HfD scans. Assessment of MBFs for FD and HfD protocols revealed bias in the MBF assessments of 0.09 ml/g/min (global MBF, FD = 1.03 ± 0.29 vs HfD = 0.94 ± 0.22 ml/g/min (p = 0.001)). Exclusion of patients with visually identified saturation effects (N = 4) reduced the bias to 0.05 ml/g/min (global MBF, FD = 0.97 ± 0.28 vs HfD = 0.92 ± 0.23 ml/g/min (p = 0.02)). From the datasets without saturation effect, it was possible to generate a bias-correction: Corrected MBFHfD = 1.09*MBFHfD-0.03 ml/g/min. MBFFD and MBFHfD did not differ following the bias correction (MBFFD = 0.97 ± 0.28, MBFHfD,corrected = 0.98 ± 0.25 ml/g/min, p = 0.77). CONCLUSION: Saturation effects can be problematic in 82Rb MBF studies using the recommended FD protocols for 3D PET/CT scanners. The use of HfD protocol eliminates the risks of saturation and should be used instead of clinical protocols to avoid erroneous results.
引用
- Lassen ML, Manabe O, Otaki Y, et al. 3D PET/CT 82Rb PET myocardial blood flow quantification: comparison of half-dose and full-dose protocols. Eur J Nucl Med Mol Imaging. 2020. PMID: 32372228. doi:10.1007/s00259-020-04811-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。